Yazar "Kaya, Bilkay Serez" seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Case of Prolonged Viral Shedding: Chronic, Intermittan COVID-1 9?(Aves, 2022) Kaya, Bilkay Serez; Yilmam, Ilker; Edis, Ebru Cakir; Karabulut, Derya; Mert, Tulin Elmaslar; Eryildiz, Canan; Demir, MuzafferCOVID-19 is a pandemic that has been affecting the entire world and has caused the death of approximately 2.8 million people. Although the duration of viral shedding varies, an average of 7-10 days is accepted. It is still unclear whether prolonged viral shedding means prolonged contagious period and whether COVID-19 will become chronic or not. This article presents a case with hematological malignancy (lymphoma) with the longest polymerase chain reaction positivity that we could find in the literature (110 days in total).Öğe A Case with Avascular Bone Necrosis Developing as a Complication of COVID-19 Treatment(2021) Yılmam, İlker; Kaya, Bilkay Serez; Edis, Ebru Çakır; Ustabaşıoğlu, Fethi Emre; Çopuroğlu, CemAs our knowledge and experience of COVID-19 increases, our treatment approaches may change. For patients with respiratory failure due to COVID-19 disease, the disease table can be better controlled with systemic glucocorticoids, and mortality rates and hospitalization periods can also be reduced. Steroid therapy can be applied for the long-term, especially in cases with organized pneumonia, and patients can be discharged from hospital with maintenance treat- ment. Complications have been noted in patients in the post-COVID period resulting from the use of glucocorticoids. While mostly bacterial and fungal lung infections are seen, another side-effect of gluco- corticoids is their negative effect on bone metabolism. We present here a case in which avascular bone necrosis developed as a result of long-term steroid use for the treatment of COVID-19.Öğe Evaluation of insomnia in healthcare personnel after COVID-19 vaccination(Kare Publ, 2023) Yilmam, Ilker; Kaya, Bilkay Serez; Temelli, Suereyya; Edis, Ebru Cakir; Yulugkural, ZerrinBACKGROUND AND AIM: Sleep disturbances are common during Coronavirus Disease 2019 (COVID-19) infection. Coronasomnia is a concept used to identify sleep disturbances observed during the pandemic. Although coronasomnia has been described during and after coronavirus infection, no data on sleep disturbances seen after vaccinations have been found. The aim of this study was to detect the prevalence of sleep disturbances observed after COVID-19 vaccinations (specifically CoronaVac).METHODS: In April 2021, healthcare personnel who had received the CoronaVac vaccine were administered questionnaires to investigate potential adverse effects of the vaccine and any sleep disturbances. RESULTS: The study included 787 individuals, of whom 506 (64.3%) were women. The mean age was 35 +/- 9.6 (19-65) years. 303 (38.5%) healthcare workers reported adverse effects after vaccination. The most common adverse effects were exhaustion, muscle pain, and headache. At least one sleep disturbance (difficulty falling asleep, frequent awakening, difficulty maintaining sleep, excessive daytime sleepiness, and need to use sleeping pills) that did not exist before vaccination but occurred afterwards was found in 86 (10.9%) participants. Women had higher insomnia scores than men (p=0.02). An important result of the study is that the insomnia scores of healthcare workers who had COVID-19 are statistically higher than those who did not (p=0.02).CONCLUSIONS: Adequate sleep is important for both protection from infection and the immune response against infection. Although coronasomnia developing after the COVID-19 variant that was identified at the beginning of the pandemic is well-defined, we believe that effects such as sleep disorders that may develop after vaccination should be monitored in the long term and in a large population.Öğe Fear in Patients Undergoing Bronchoscopy and Its Causes(2022) Özkan, Zeynep Kızılcık; Kaya, Bilkay Serez; Kansun, Emine; Gacemer, NihalObjective: Bronchoscopy is an invasive procedure that can cause a feeling of suffocation and cough. It may cause fear, discomfort, and anxiety in individuals. The aim of this research is to determine the fear and its causes before the procedure in patients undergoing bronchoscopy. Methods: This descriptive research was conducted between April 2019 and September 2019 with the participation of 138 patients who underwent elective bronchoscopy with various indications in the endoscopy unit of a university hospital. “Patient Information Form” and “Bronchoscopy Fear Questionnaire” were used for data collection. The data were analyzed using Chi-squared test in IBM SPSS 22.0 program. The level of significance in statistical analysis was accepted as p<0.05. Results: It was found that the average age of the patients was 62.4±11.5 (24–88) years. Of these patients, 79.7% (n=110) of them were males and 78.3% (n=108) were primary school graduates. It was found that 57.2% of the patients (n=79) felt fear of the bronchoscopy process in general. However, 93.5% of the patients agreed to undergo the procedure under the same conditions when necessary. It was determined that the patients’ fear of the bronchoscopy procedure differed statistically significantly according to age and gender (p<0.05). Conclusion: These research results reveal that patients who undergo bronchoscopy experience fear of the process in general and that male patients or patients over the age of 61 are more prone to procedural fear. To optimize patient comfort and satisfaction, it is recommended that physicians and nurses working in endoscopy units question the presence of procedural fear before the procedure and help patients reduce their fears.Öğe Pulmonary Embolism after COVID-19 Infection in two Non-hospitalized Cases(2021) Yılmam, İlker; Kaya, Bilkay Serez; Edis, Ebru ÇakırSARS-CoV2 infection caused by Severe Acute Res- piratory Syndrome Coronavirus 2 (SARS-CoV2) may result in thrombosis development in both venous and arterial systems under the effects of inflammation increase, thrombocyte activation, endothelial dysfunc- tion and stasis in blood flow. Accordingly, although many guidelines recommend thrombosis prophylaxis for hospitalized patients, it is not recommended for outpatients. Pulmonary embolisms were detected on computed tomography examinations performed in the emergency department in the two patients in the present study, who were being treated for coronavirus disease-19 (COVID-19) infection, but who did not require hospitalization, and who presented with com- plaints of shortness of breath and chest pain after treatment. We deemed it appropriate to present these cases in non-hospitalized patients to emphasize the need for thrombosis prophylaxis, considering the balance of bleeding and thrombosis
